SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-059386
Filing Date
2023-11-06
Accepted
2023-11-06 16:07:05
Documents
14
Period of Report
2023-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcvx-20231106.htm   iXBRL 8-K 48014
2 EX-99.1 pcvx-ex99_1.htm EX-99.1 234546
3 GRAPHIC img251305552_0.jpg GRAPHIC 9918
  Complete submission text file 0000950170-23-059386.txt   429538

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20231106.xsd EX-101.SCH 2466
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20231106_pre.xml EX-101.PRE 10288
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20231106_lab.xml EX-101.LAB 14028
8 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20231106_htm.xml XML 4927
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 231380005
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences